Physician profile
Jeffrey Knabe
NPI 1750674446
$3,829.74
in general payments reported to CMS, 2019-2025
15 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,278 · 2020: $46.64 · 2021: $598 · 2022: $818 · 2023: $238 · 2024: $543 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,089.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,647.35 | 2019-2025 | Alphavent, Salvation, Flexible Guide Pin (Stryker Acl Versitomic) |
| Medinc of Texas | $344.33 | 2021 | |
| Depuy Synthes Sales INC. | $146.75 | 2019 | |
| Medtronic, INC. | $142.29 | 2024 | Vanta Adaptivestim |
| Arthrex, INC. | $140.37 | 2019 | |
| Alafair Biosciences, INC. | $82.36 | 2019 | |
| Bioventus LLC | $54.77 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Baxter Healthcare | $48.39 | 2025 | Tisseel |
| Axogen | $47.45 | 2019 | |
| Endo Pharmaceuticals INC. | $46.86 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.69 | 2019 | |
| Smith+Nephew, INC. | $30.89 | 2021 | |
| Aytu Biopharma, INC. | $22.89 | 2019 | |
| Abbott Laboratories | $21.33 | 2019 | |
| Sanofi Pasteur INC. | $17.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Knabe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.